The anti-tumor effects of two novel multivalent/multifunctional agents derived from hR1, a humanized anti-insulin-like growth factor receptor-I monoclonal antibody, are enhanced in renal cell carcinoma and synergistic with an mTOR inhibitor

被引：0

作者：

Cardillo, Thomas M. ^{[1
]}

Nair, Anju ^{[1
]}

Zalath, Maria ^{[1
]}

Arrojo, Roberto ^{[1
]}

Trisal, Preeti ^{[1
]}

Rossi, Edmund A. ^{[2
]}

Goldenberg, David M. ^{[3
]}

Chang, Chien-Hsing ^{[2
]}

机构：

[1] Immunomed Inc, Morris Plains, NJ USA

[2] IBC Pharmaceut Inc, Morris Plains, NJ USA

[3] Ctr Mol Med & Immunol, Morris Plains, NJ USA

来源：

关键词：

D O I：

10.1158/1538-7445.AM2012-4402

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4402

引用

页数：1